Biased Signaling Atlas

piclidenoson

Agent/drug
Bioactivity

piclidenoson

SMILES	CNC(=O)C1OC(n2cnc3c(NCc4ccc(I)cc4)ncnc32)C(O)C1O
InChIKey	JTZRECOPNKCRTE-MOROJQBDSA-N

Chemical Properties

Hydrogen bond acceptors	8
Hydrogen bond donors	4
Rotatable bonds	5
Molecular weight (Da)	510.3

Database connections

ChEMBL_compound_ids PubChem PubChem GPCRdb

No bioactivity data available.

piclidenoson

Drug properties

Molecular type	Small molecule
Physiological/Surrogate	Surrogate
Approved drug	No

Clinical Trials

Phase I 0

Phase II 3

Phase III 3

Approved No

Database connections

ChEMBL_compound_ids PubChem PubChem GPCRdb

Sankey plot

Drug Information

Search:

Target					Disease				Phase

Gene	Protein	Receptor family	Ligand type	Class	Indication name	ICD11	ATC	Association score	Phase	Approved

AA3R	A₃ receptor	Adenosine receptors	Nucleotide receptors	Class A	COVID-19	RA01		0.097	2	No
AA3R	A₃ receptor	Adenosine receptors	Nucleotide receptors	Class A	Glaucoma, unspecified	9C61.Z		0.080	2	No
AA3R	A₃ receptor	Adenosine receptors	Nucleotide receptors	Class A	Ocular hypertension	9C61.01		0.076	2	No
AA3R	A₃ receptor	Adenosine receptors	Nucleotide receptors	Class A	Other specified disorders of lacrimal apparatus	9A1Y		0.278	3	No
AA3R	A₃ receptor	Adenosine receptors	Nucleotide receptors	Class A	Psoriasis of unspecified type	EA90.Z		0.298	3	No
AA3R	A₃ receptor	Adenosine receptors	Nucleotide receptors	Class A	Rheumatoid arthritis, serology unspecified	FA20.Z		0.296	3	No

Showing 1 to 6 of 6 entries